CLONING OF A COMPLEMENTARY DEOXYRIBONUCLEIC-ACID ENCODING THE MURINE HOMOLOG OF THE VERY-LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN-E RECEPTOR - EXPRESSION PATTERN AND ASSIGNMENT OF THE GENE TO MOUSE CHROMOSOME-19
Me. Gafvels et al., CLONING OF A COMPLEMENTARY DEOXYRIBONUCLEIC-ACID ENCODING THE MURINE HOMOLOG OF THE VERY-LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN-E RECEPTOR - EXPRESSION PATTERN AND ASSIGNMENT OF THE GENE TO MOUSE CHROMOSOME-19, Endocrinology, 135(1), 1994, pp. 387-394
We report the cloning of a complementary DNA for the mouse homolog of
the very low density lipoprotein (VLDL)/apolipoprotein-E receptor (VLD
LR), the deduced amino acid sequence of the protein, and the mapping o
f the gene encoding the receptor to mouse chromesome 19. Northern hybr
idization revealed that the VLDLR messenger RNA (mRNA) is most abundan
t in skeletal muscle, heart, kidney, and brain. It was also detected i
n lung and in low levels in liver, but it was not found in spleen or t
estes. Levels of VLDLR mRNA in mouse placenta increased from days 8-18
of gestation. The VLDLR mRNA was induced in 3T3-L1 cells undergoing d
ifferentiation into adipocytes. The increase in VLDLR mRNA paralleled
the rise in lipoprotein lipase and hormone-sensitive lipase mRNAs. How
ever, VLDLR and low density lipoprotein receptor-related protein were
increased in the presence of retinoic acid, whereas the induction of l
ipoprotein lipase and hormone-sensitive lipase mRNAs was inhibited. Ou
r observations demonstrate regulated expression of the VLDLR gene in p
lacenta and adipocytes, where the receptor protein may play roles in t
he uptake of triglyceride-rich particles for storage of lipid (adipocy
tes) or for lipid transport to the fetus (placenta). The availability
of a murine complementary DNA probe and the knowledge of the map posit
ion of the VLDLR gene in the mouse genome will facilitate studies on t
he function and regulation of this protein.